A robust covariate-balancing method for estimating individualized treatment with censored data
Biometrics · 06.01.2026 · 82 (1)
DOI: 10.1093/biomtc/ujag050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, online erschienen am 19.03.2026. Verfasst von Rujia Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Applied Statistics of MOE and School of Mathematics and Statistics, Northeast Normal University, Changchun 130024, China. Hauptthemen laut MEDLINE: Precision Medicine, Models, Statistical. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
One of the most essential aspects of precision medicine is the identification of optimal individualized treatment regimen, which recommends treatment decisions to maximize a patient’s expected survival time based on their individual characteristics with censored data. Typically, the expected survival time is required to be estimated first, which is usually based on the posited weighting models (propensity score model and censoring model) or the posited outcome model. However, if any of the above models is misspecified, the estimated treatment regimen is not reliable. In this paper, we consider the contrast value function defined for survival analysis, and propose two robust covariate-balancing estimators of the contrast value function by balancing the covariates of patients through censoring probability and survival function of censoring time in the weights, respectively. Theoretical results prove that the proposed estimators are doubly robust and asymptotically normal under standard regularity conditions. A large number of simulations show the superiority of our methods over the existing methods. We further apply the proposed methods to the China Rural Hypertension Control Project to identify the individualized medication regimens for hypertensive patients by tailoring their individual characteristics to maximize the expected survival time. The results indicate that the estimated optimal treatment regimen improves patients’ survival probability over the 36-month follow-up period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory for Applied Statistics of MOE and School of Mathematics and Statistics, Northeast Normal University, Changchun 130024, China.
- Department of Cardiology, the First Hospital of China Medical University, Shenyang 110001, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zheng, R., Zhu, W., & Guo, X. (2026). A robust covariate-balancing method for estimating individualized treatment with censored data. Biometrics, 82(1). https://doi.org/10.1093/biomtc/ujag050
Vancouver
Zheng R, Zhu W, Guo X. A robust covariate-balancing method for estimating individualized treatment with censored data. Biometrics. 2026;82(1). doi:10.1093/biomtc/ujag050
BibTeX
@article{Zheng2026,
author = {Zheng, Rujia and Zhu, Wensheng and Guo, Xiaofan},
title = {A robust covariate-balancing method for estimating individualized treatment with censored data},
journal = {Biometrics},
year = {2026},
volume = {82},
number = {1},
doi = {10.1093/biomtc/ujag050}
}
EUVIMED